60 related articles for article (PubMed ID: 30782303)
1. The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis.
Li G; Wang Z; Xu J; Wu H; Cai S; He Y
BMC Cancer; 2016 Mar; 16():249. PubMed ID: 27016045
[TBL] [Abstract][Full Text] [Related]
2. Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis.
Zhang J; Tang X; Zhang W; Xu Y; Zhang H; Fan Y
Clin Nutr; 2024 May; 43(7):1618-1625. PubMed ID: 38788267
[TBL] [Abstract][Full Text] [Related]
3. Naples prognostic score as a predictor of outcomes in lung cancer: a systematic review and meta-analysis.
Wang YS; Niu L; Shi WX; Li XY; Shen L
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8144-8153. PubMed ID: 37750642
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
Arora H; Mammi M; Patel NM; Zyfi D; Dasari HR; Yunusa I; Simjian T; Smith TR; Mekary RA
J Neurooncol; 2024 Jan; 166(1):17-26. PubMed ID: 38151699
[TBL] [Abstract][Full Text] [Related]
5. Serum lactate dehydrogenase and survival following cancer diagnosis.
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Ng T; Van Hemelrijck M
Br J Cancer; 2015 Nov; 113(9):1389-96. PubMed ID: 26469834
[TBL] [Abstract][Full Text] [Related]
6. Salivary and serum levels of lactate dehydrogenase in oral submucous fibrosis: A meta-analysis.
Chen X; Chen T; Xie H; Guo J
Medicine (Baltimore); 2024 Apr; 103(15):e37788. PubMed ID: 38608075
[TBL] [Abstract][Full Text] [Related]
7. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
de Jong C; Deneer VHM; Kelder JC; Ruven H; Egberts TCG; Herder GJM
Thorac Cancer; 2020 Jul; 11(7):1790-1800. PubMed ID: 32383328
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Lactate Dehydrogenase Expression in Different Cancers: A Meta-Analysis.
Lv J; Zhou Z; Wang J; Yu H; Lu H; Yuan B; Han J; Zhou R; Zhang X; Yang X; Yang H; Li P; Lu Q
Am J Med Sci; 2019 Dec; 358(6):412-421. PubMed ID: 31813468
[TBL] [Abstract][Full Text] [Related]
9. Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
Park W; Han JH; Wei S; Yang ES; Cheon SY; Bae SJ; Ryu D; Chung HS; Ha KT
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255882
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of modified lung immune prognostic index in osteosarcoma patients.
He X; Tang F; Zou C; Li L; Wang Y; Kenmegne GR; Zhou Y; Lu M; Min L; Luo Y; Tu C
Front Genet; 2022; 13():972352. PubMed ID: 36303539
[No Abstract] [Full Text] [Related]
11. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, Cancer Antigen 153 and Cancer Antigen 125 in Metastatic Breast Cancer.
Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma.
Feng JF; Zhao JM; Chen S; Chen QX
Cancer Manag Res; 2021; 13():2811-2819. PubMed ID: 33814930
[TBL] [Abstract][Full Text] [Related]
13. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma.
Feng JF; Wang L; Yang X; Chen S
J Cancer; 2020; 11(6):1334-1340. PubMed ID: 32047540
[No Abstract] [Full Text] [Related]
14. Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma.
Feng JF; Wang L; Yang X; Jiang YH
Cancer Manag Res; 2019; 11():7243-7251. PubMed ID: 31447584
[TBL] [Abstract][Full Text] [Related]
15. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang Z; Li Y; Yan X; Song Q; Wang G; Hu Y; Jiao S; Wang J
Cancer Med; 2019 Apr; 8(4):1467-1473. PubMed ID: 30848091
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.
Liu HL; Han G; Peng M; Weng YM; Yuan JP; Yang GF; Yu JM; Song QB
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):864-872. PubMed ID: 29270745
[TBL] [Abstract][Full Text] [Related]
18. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
